Cointime

Telormedix

company

About

Telormedix is a biopharmaceutical company developing therapeutics based on targeted immunity for cancer and autoimmune diseases.

  • 1 - 10

Highlights

Total Funding Amount
$19M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$19M
Industries
Biopharma,Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Telormedix is a biopharmaceutical company focused on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$19M
Telormedix has raised a total of $19M in funding over 2 rounds. Their latest funding was raised on Sep 30, 2008 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 30, 2008 Series A $19M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Telormedix is funded by 1 investors. BSI SA are the most recent investors.
Investor Name Lead Investor Funding Round
BSI SA — Series A
Cointime
เนื้อหา
บริษัท